An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
Clinical trial NCT02180724 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02180724
- Sponsor
- Acerta Pharma BV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-11
- Primary completion
- 2019-10-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.